HAP Trading »

Fulcrum Therapeutics shares owned by HAP Trading

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by HAP Trading from 13F filings

Historical chart of HAP Trading investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by HAP Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by HAP Trading

Quarter filed Position value Share count Share price at filing
2024-03-31 $120k 50k 2.40

More positions owned by HAP Trading

Cytokinetics Com New (CYTK)
Meta Platforms Cl A Call Option (META)
Coinbase Global Com Cl A (COIN)
Zillow Group Cl C Cap Stk (Z)
Western Digital (WDC)
Metropcs Communications (TMUS)
Carvana Cl A (CVNA)
NVIDIA Corporation Call Option (NVDA)
Applovin Corp Com Cl A (APP)
Kenvue (KVUE)
Apple (AAPL)
Wayfair Cl A (W)
AmerisourceBergen Call Option (COR)
Ishares Tr Msci Emg Mkt Etf (EEM)
Mongodb Cl A (MDB)

View all positions for HAP Trading

Top funds holding Fulcrum Therapeutics

RA Capital Management
FMR
Cowen And Company
Suvretta Capital Management
Vanguard Group
Trv Gp Iv
Caption Management
BlackRock
Citadel Advisors
Dimensional Fund Advisors
Morgan Stanley
Leucadia National Corporation
MPM Oncology Impact Management
Adage Capital Partners GP
Logos Global Management

View all funds holding Fulcrum Therapeutics